Thymol Powder

Home / Products / Animal Nutrition / CrysVital® Essential Oils
CrysVital® Essential Oils

CrysVital® Essential Oils

Ultra-stable essential oils that are an ideal antibiotic alternative for animal gut hλealth.

  • Patent protected

  • Superior stability

  • White powder completely water soluble

  • Low volatility

Benefits

Essential oils (EO) are secondary metabolites of plants, primarily serv‌ing to defend bacteria, fungi, and insect attack in nature. The active  ingredients of essential oils include terpenes, terpenoi↔ds and aromatic compounds. 


  • Antibacterial and anti-inflammatory
  • Support gut health
  • Enhance immunity

Why CrysVital®

Essential oils are typically characterized as having very low solubility and high volatility. T×he unfavorable properties present a challenge to the maintenance of its biological activ↑ity.

CrysVital® Essential Oils is a patented product developed using cocrystal technology, in wh÷ich thymol/carvacrol and coformer are combined through hydrogen bondi×ng. Compared to the conventional essential oils, CrysVital® ♣Essential Oils significantly enhance the stability and solubility, leading∞ to effectively improved efficacy and performance in feed i←ndustry.

What CrysVital® does







  • Improved Stability

    Compared to conventional essential oils, CrysVital® Essential Oils has a higher melting point and ♣lower volatility. This is more suitable for pelleting and expand←ing process of the animal feed.
  • Higher Solubility

    CrysVital® Essential Oils shows visible dissolution within 0. 8 seconds, ensuring rapid delivery of active ingredients to the animals. 

  • Superior Performance

    The effect of CrysVital® Essential Oils have been supported by ani♠mal experiments.

Ingredient Content And Addition

  1. Active Ingredients: Carvacrol, Thymol, L-proline
  2. Applicable Animals: All animal species 
  3. Directions for Use: Mix with animal feed, or drinking water

Patents

CHN Patent Number: ZL 202110260473.5

JAP Patent Number:特許第7628625号

USA Publication Number:US 2024-0140897A1

EUR Publication Number:EP 4306507A1

PCT Application Number:PCT/CN2022/077567